Research Article
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
Table 2
Multivariate analysis of the overall survivals of patients in the training cohort.
| Variables | Overall survival | HR | 95% CI | P |
| Age at diagnosis, years | 1.025 | 1.001−1.049 | 0.042 | Clonal BM plasma cells | 1.026 | 1.016−1.035 | < 0.001 | Serum albumin | | | | ⩾35 g/L | | | | <35 g/L | 1.043 | 0.589−1.846 | 0.885 | Serum LDH | | | | <250 U/L | | | | ⩾250 U/L | 1.769 | 1.002−3.124 | 0.049 | Serum β2-microglobulin | | | | <5.5 mmol/L | | | | ≥5.5 mmol/L | 1.709 | 1.041−2.807 | 0.034 | 1q21 gain (positive vs negative) | 1.091 | 0.660−1.803 | 0.735 | del (17p) (positive vs negative) | 3.008 | 1.654−5.468 | < 0.001 |
|
|
Abbreviations: HR, hazard ratio; CI, confidence interval; BM, bone marrow; LDH, lactate dehydrogenase.
|